Filter
7366
Filtered Results: 7366
Text search:
Centers
for
Disease
Control
and
Prevention
Featured
Recommendations
716
New Publications
1855
Language
Document type
No document type
3956
Studies & Reports
1097
Guidelines
1051
Manuals
364
Strategic & Response Plan
265
Fact sheets
251
Training Material
112
Infographics
75
Resource Platforms
74
Situation Updates
73
Brochures
25
Online Courses
11
Videos
8
Dashboards/Maps
2
App
2
Countries / Regions
India
326
Global
312
Sierra Leone
206
Liberia
193
Kenya
178
Ethiopia
163
Africa
162
Nigeria
157
Western and Central Europe
147
Uganda
124
Latin America and the Carribbean
111
Nepal
109
South Africa
103
Congo, Democratic Republic of
102
Rwanda
100
West and Central Africa
97
Malawi
96
Guinea
94
Zambia
90
Middle East and North Africa
87
Syria
85
Tanzania
85
Senegal
83
Mozambique
83
Ghana
77
Bangladesh
76
East and Southern Africa
74
Ukraine
69
South Sudan
67
Haiti
66
Myanmar / Burma
64
Philippines
61
Burkina Faso
60
Namibia
60
Eastern Europe
58
Russia
55
Germany
52
Yemen
52
Brazil
49
Guinea-Bissau
46
Zimbabwe
45
South–East Asia Region
43
Mali
42
Asia
42
Côte d’Ivoire / Ivory Coast
38
Cambodia
38
Angola
38
Lesotho
36
Cameroon
33
Indonesia
33
Chad
28
Colombia
28
Eastern Europe and Central Asia
28
Venezuela
27
Niger
24
Botswana
23
USA
21
Madagascar
21
Eswatini/ Swaziland
18
Somalia
17
Pakistan
16
Afghanistan
15
Sudan
15
Central African Republic
15
Western Pacific Region
15
Thailand
14
Argentina
14
Benin
13
Paraguay
13
Vietnam
13
Albania
12
Jordan
11
Tajikistan
11
Moldova
11
Lebanon
10
Peru
10
Ecuador
10
Iraq
9
China
9
Chile
9
Laos
9
Saudi Arabia
8
Togo
8
Egypt
8
Georgia
8
North America
8
Spain
8
North Macedonia
7
Burundi
7
Bolivia
7
Palestine
7
Sri Lanka
6
Armenia
6
Portugal
6
Turkey
5
Gambia
5
Papua New Guinea
5
Mexico
5
Poland
5
Timor Leste/ East Timor
5
Romania
5
Hungary
4
Libya
4
Canada
4
Kazakhstan
4
Japan
4
France
4
Honduras
3
El Salvador
3
Bhutan
3
Djibouti
3
Southern Africa
3
Iran
3
Gabon
3
Turkmenistan
3
Tunisia
3
United Kingdom
3
Belarus
3
Morocco
2
Malaysia
2
Ireland
2
Greece
2
Other region
2
Italy
2
Congo-Brazzaville
2
Qatar
2
Bulgaria
2
Estonia
2
Slovakia
2
Uzbekistan
2
Kyrgyzstan
2
Jamaica
2
Belgium
2
Mauritius
2
Mauritania
1
Singapore
1
Dominican Republic
1
Austria
1
Switzerland
1
Serbia
1
Cape Verde
1
Fiji
1
North Korea
1
Lithuania
1
Australia
1
Uruguay
1
Maldives
1
South Korea
1
Morocco
1
Israel
1
Authors & Publishers
Publication Years
Category
Countries
2735
Clinical Guidelines
598
Public Health
431
Key Resources
302
Women & Child Health
263
Capacity Building
104
Pharmacy & Technologies
94
Annual Report MEDBOX
2
Toolboxes
COVID-19
995
HIV
541
TB
476
Ebola
422
Mental Health
416
Rapid Response
300
AMR
279
NTDs
242
Planetary Health
198
NCDs
178
Caregiver
162
Conflict
143
Refugee
130
Zika
121
Disability
102
Pharmacy
99
Global Health Education
90
Cholera
84
Natural Hazards
79
Specific Hazards
51
Health Financing Toolbox
50
Polio
48
Social Ethics
8
Typhoon
3
South Sudan
2
Health Financing
2
Infection prevention and control (IPC) practices are of critical importance in protecting the function of healthcare services at all levels ... mitigating the impact on vulnerable populations. Although the management of possible COVID-19 cases is usually guided by national policies for specific healthcare facilities, community transmission is currently widespread in most EU/EEA countries and the UK, therefore primary healthcare providers in the community such as GPs, dentists and pharmacists are at risk of being exposed to COVID-19.
This document aims to provide guidance to healthcare facilities and healthcare providers in the European Union/European Economic Area (EU/EEA) and the United Kingdom (UK) on preparedness ... infection prevention and control (IPC) measures for the management of possible and confirmed cases of COVID-19 in healthcare settings, including long-term care facilities (LTCFs). In addition, this document addresses the management of clinical diagnostic specimens at laboratories in the EU/EEA. This is the sixth update of the ECDC guidance on ‘Infection prevention and control and preparedness for COVID-19 in healthcare settings’, and replaces the document dated 6 October 2020.
This document provides guidance on the implementation of the shielding approach in urban areas in LICs and crisis-affected regions. It is intended for the community itself, national ... local governance institutions, and humanitarian and development actors operating in the country.
Infection Prevention and Control Programmes
January 2020
Cholera is an acute gastrointestinal infection caused by the bacterium Vibrio Cholerae serogroup O1 or O139, and is often linked to unsafe drinking water, lack of proper sanitation and personal hygi...
These guidelines provide recommendations for the non-pharmacological aspects of infection prevention and ... for acute respiratory diseases (ARD) in health care. Administrative and infection controls, including early detection, isolation and reporting, and establishment of infection control infrastructure, are key components for containment and mitigation of the impact of pathogens that may constitute a major public health threat. In these guidelines, the options of using natural ventilation and/or exhaust fan assisted ventilation in health-care facilities (HCF) are considered.
Developed by the HHS Panel on Treatment of Pregnant Women with HIV Infection and Prevention of Perinatal Transmission—
A Working Group of the Office of AIDS Research Advisory Council (OARAC)
A...
The WHO document "Integrating the prevention and control of noncommunicable diseases in HIV/AIDS...
The Infection prevention and control in the context of coronavirus disease 2019 (COVID-19): a li...
Epidemiology
Chagas disease (American trypanosomiasis) is caused by the protozoan parasite Trypanosoma cruzi, and transmitted to humans by infected triatomine bugs, ... less commonly by transfusion, organ transplant, from mother to infant, and in rare instances, by ingestion of contaminated food or drink.1-4 The hematophagous triatomine vectors defecate during or immediately after feeding on a person. The parasite is present in large numbers in the feces of infected bugs, and enters the human body through the bite wound, or through the intact conjunctiva or other mucous membrane.
Vector-borne transmission occurs only in the Americas, where an estimated 8 to 10 million people have Chagas disease.5 Historically, transmission occurred largely in rural areas in Latin America, where houses built of mud brick are vulnerable to colonization by the triatomine vectors.4 In such areas, Chagas disease usually is acquired in childhood. In the last several decades, successful vector control programs have substantially decreased transmission rates in much of Latin America, and large-scale migration has brought infected individuals to cities both within and outside of Latin America.
Building on the 2021 Interim guidance, this second version and update, incorporates the lessons and feedback from the hepatitis pilots that successfully demonstrated the feasibility of measuring hep...
In 2005, the World Health Organization (WHO) recognized Chagas disease (CD; Trypanosoma cruzi infection) as a neglected tropical disease (NTD) [1] and...
Interim rapid response guidance, 10 June 2022.
It includes considerations for certain populations such as patients with mild disease with considerations ... community care, patients with moderate to severe disease, sexually active persons, pregnant or breastfeeding women, children and young persons. The guidance also addresses considerations for clinical management such as the use of therapeutics, nutritional support, mental health services, and post-infection follow-up.
The document provides guidance for clinicians, health facility managers, health workers and infection prevention and control practitioners including but not limited to those working in primary care clinics, sexual health clinics, emergency departments, infectious diseases clinics, genitourinary clinics, dermatology clinics, maternity services, paediatrics, obstetrics and gynaecology and acute care facilities that provide care for patients with suspected or confirmed monkeypox
The WHO continuously reviews available data on SARS-CoV-2 variants of concern. For this version, the global epidemiological
situation of the COVID-19 pandemic as of 21 January 2022 – at a time when the Omicron VOC had been identified in 171
coun...
The Infection prevention and control in the context of coronavirus disease 2019 (COVID-19): a li...
The most significant finding of the case study for integrating antimicrobial resistance (AMR)into existing programs and mobilising resources fo... funding in Nigeria, is that most of the AMR activities within the Nigerian National Action Plan (NAP)canalready be incorporated within existing programs of the Federal Ministry of Health (FMOH), Federal Ministry of Agriculture and Rural Development (FMARD) and their agencies or institutes. Certain programs and initiatives already have an AMR element incorporated or could,with little effort,include some additional AMR actions, however much is already being planned and has started with existing federal funding and existing staffing and other resources including development partner support and is being driven by significant political will from the ministries as well as implementation support from the Nigerian Centers for Disease Control as the focal point.
India is experiencing rapid demographic and epidemiological transitions with NCDs causing significant disability, morbidity and mortality both in urban an... rural populations and across all socioeconomic strata. According to the ICMR State Level Disease Burden Initiative, in 2016, NCDs accounted to an estimated 6.0 million deaths, constituting 62% of the total mortality of that year.
As part of our commitment to the fight against NCDs, Nigeria was signatory to the political declaration at the UN General Assembly High Level Meeting on NCDs in September 2011. Thus, the purpose of this document is to develop and... ensure the implementation of policies and programmes that will engender and guarantee a healthy lifestyle and quality health for all Nigerians. The core sections include background, scope of the policy, policy goal, strategic thrusts for implementation, programme management and coordination, roles of stakeholders and partnership coordination. It is expected that with the adoption of this policy, the control and prevention of NCDs and their associated risk factors will be well integrated at all levels of government and health care delivery system in Nigeria. This policy document is therefore a stepping stone towards the development of guidelines for the prevention and management of NCDs.
